Learn about our Nerve-On-A-Chip and Mini-Brain platforms!
AxoSim leverages 3D Nerve-on-a-Chip technology to accelerate the development of safer, more effective therapies. Our cell-based platform enables clinically relevant structural and functional endpoints, serving as an alternative to costly animal testing and ineffective 2D models. AxoSim's diverse team of scientists and engineers are committed to tackling critical problems in pharmaceutical research. Our portfolio of services includes assays for neurotoxicity, pain, and neurodegenerative diseases.